Guangxi Wuzhou Zhongheng Group Co Ltd
SSE:600252
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Guangxi Wuzhou Zhongheng Group Co Ltd
SSE:600252
|
CN |
|
Jhaveri Credits and Capital Ltd
BSE:531550
|
IN |
|
ME Group International PLC
LSE:MEGP
|
UK |
|
Aquis Exchange PLC
LSE:AQX
|
UK |
|
TPG Telecom Ltd
ASX:TPG
|
AU |
|
N
|
Nyocor Co Ltd
SSE:600821
|
CN |
|
N
|
Nahar Capital and Financial Services Ltd
NSE:NAHARCAP
|
IN |
|
C
|
Cheuk Nang Holdings Ltd
HKEX:131
|
HK |
|
Vienna Insurance Group AG Wiener Versicherung Gruppe
OTC:VNRGF
|
AT |
|
Central Garden & Pet Co
NASDAQ:CENT
|
US |
|
Feintool International Holding AG
SIX:FTON
|
CH |
|
P
|
Prakash Pipes Ltd
BSE:542684
|
IN |
|
Global Arena Holding Inc
OTC:GAHC
|
US |
|
Aydem Yenilenebilir Enerji AS
IST:AYDEM.E
|
TR |
|
F
|
Fincera Inc
OTC:YUANF
|
US |
|
V
|
VIMAB Group AB (publ)
STO:VIMAB
|
SE |
|
Cyanconnode Holdings PLC
LSE:CYAN
|
UK |
|
S
|
Shanghai Model Organisms Center Inc
SSE:688265
|
CN |
|
N
|
Nichicon Corp
TSE:6996
|
JP |
|
Asaka Riken Co Ltd
TSE:5724
|
JP |
|
Delta Resources Ltd
XTSX:DLTA
|
CA |
|
Bigtincan Holdings Ltd
ASX:BTH
|
AU |
|
Mid-Southern Bancorp Inc
OTC:MSVB
|
US |
|
S
|
Shin Yang Group Bhd
KLSE:SYGROUP
|
MY |
Relative Value
The Relative Value of one
Guangxi Wuzhou Zhongheng Group Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 2.46 CNY,
Guangxi Wuzhou Zhongheng Group Co Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Guangxi Wuzhou Zhongheng Group Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Guangxi Wuzhou Zhongheng Group Co Ltd
SSE:600252
|
7.9B CNY | 3.4 | -21.6 | -15 | -15 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
865.7B USD | 13.3 | 41.9 | 28.3 | 30.2 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
577.7B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.4B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
295.4B USD | 4.5 | 16.2 | 10 | 12.2 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.2B GBP | 5 | 28.6 | 15.9 | 22.4 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.4B CHF | 5.2 | 21.1 | 13.1 | 16.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.4 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.1B USD | 2.5 | 20 | 7.7 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
118.6B USD | 2.5 | 16.8 | 7.1 | 8.8 |